Impact of Confinement in Patients under Long-Term Noninvasive Ventilation during the First Wave of the SARS-CoV-2 Pandemic: A Remarkable Resilience

Cantero, Chloé; Pasquina, Patrick; Dao, Melissa Dominicé; Cedraschi, Christine; Adler, Dan; Plojoux, Jérôme; Janssens, Jean–Paul

doi:10.1159/000516327

Cited by 2 publications

(1 citation statement)

References 42 publications

(56 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Detailed analysis of day by day use of devices reveals behavioral patterns which improve our understanding of how patients adhere and accept their treatment ( 86 , 87 ). Recently, it has been possible through telemonitoring to evaluate the impact of the lockdown during the COVID pandemic on adherence to CPAP or NIV ( 88 , 89 ). Undoubtedly, in a near future, this type of information will become increasingly available and provide a useful adjunct to clinical trials.…”

Section: Introductionmentioning

confidence: 99%

Monitoring Long Term Noninvasive Ventilation: Benefits, Caveats and Perspectives

Janssens

Cantero

Pasquina³

et al. 2022

Front. Med.

Self Cite

View full text Add to dashboard Cite

Long term noninvasive ventilation (LTNIV) is a recognized treatment for chronic hypercapnic respiratory failure (CHRF). COPD, obesity-hypoventilation syndrome, neuromuscular disorders, various restrictive disorders, and patients with sleep-disordered breathing are the major groups concerned. The purpose of this narrative review is to summarize current knowledge in the field of monitoring during home ventilation. LTNIV improves symptoms related to CHRF, diurnal and nocturnal blood gases, survival, and health-related quality of life. Initially, patients with LTNIV were most often followed through elective short in-hospital stays to ensure patient comfort, correction of daytime blood gases and nocturnal oxygenation, and control of nocturnal respiratory events. Because of the widespread use of LTNIV, elective in-hospital monitoring has become logistically problematic, time consuming, and costly. LTNIV devices presently have a built-in software which records compliance, leaks, tidal volume, minute ventilation, cycles triggered and cycled by the patient and provides detailed pressure and flow curves. Although the engineering behind this information is remarkable, the quality and reliability of certain signals may vary. Interpretation of the curves provided requires a certain level of training. Coupling ventilator software with nocturnal pulse oximetry or transcutaneous capnography performed at the patient's home can however provide important information and allow adjustments of ventilator settings thus potentially avoiding hospital admissions. Strategies have been described to combine different tools for optimal detection of an inefficient ventilation. Recent devices also allow adapting certain parameters at a distance (pressure support, expiratory positive airway pressure, back-up respiratory rate), thus allowing progressive changes in these settings for increased patient comfort and tolerance, and reducing the requirement for in-hospital titration. Because we live in a connected world, analyzing large groups of patients through treatment of “big data” will probably improve our knowledge of clinical pathways of our patients, and factors associated with treatment success or failure, adherence and efficacy. This approach provides a useful add-on to randomized controlled studies and allows generating hypotheses for better management of HMV.

show abstract